SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-18-006672
Filing Date
2018-05-11
Accepted
2018-05-11 16:56:48
Documents
1
Period of Report
2018-05-09

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3912
  Complete submission text file 0001493152-18-006672.txt   5600
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCBIOMUNE PHARMACEUTICALS INC., 11441 INDUSTRIPLEX BLVD, SUITE 190 BATON ROUGE LA 70809
Business Address
Hoverman Daniel S. (Reporting) CIK: 0001665931 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 18827686